Chemical Compound
VILANTEROL TRIFENATATE
CAS Registry Number
503070-58-4
Primary Record
VILANTEROL TRIFENATATE
- In stock
- 2,962 g
- Purity
- 98.1 %
- CAS
- 503070-58-4
Compound Identifiers & Properties
- CAS
- 503070-58-4
- PubChem CID
- 44482554
- SMILES
- C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl
- Canonical SMILES
- O=C(O)C(c1ccccc1)(c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O
Names & Synonyms
- VILANTEROL TRIFENATATE
- vilanterol trifenate
- Vilanterol
- 503070-58-4
- UNII-40AHO2C6DG
- Vilanterol (trifenatate)
- Vilanterol triphenatate
- Vilanterol (as trifenatate)
- Vilanterol trifenatate?
- 40AHO2C6DG
- GW642444M
- Vilanterol trifenatate [USAN]
- RefChem:901855
- vilanterol triphenylacetate
- C44H49Cl2NO7
- CHEBI:75040
- GW-642444M
- SCHEMBL164639
- VILANTEROL TRIFENATATE [MI]
- CHEMBL1084172
- GW 642444M
- SCHEMBL29352172
- VILANTEROL TRIFENATATE [JAN]
- DTXSID80659232
- GLXC-15302
- GW642444x
- HMS3885O21
- AMY30059
- BCP18862
- EX-A4159
- Vilanterol trifenatate (JAN/USAN)
- VILANTEROL TRIFENATATE [WHO-DD]
- HY-14300A
- MFCD28978327
- s3727
- AKOS040758713
- ACN-041379
- CCG-270458
- CS-1679
- EBC-101049
- VILANTEROL TRIFENATATE [ORANGE BOOK]
- DA-68585
- A15998
- ANORO ELLIPTA COMPONENT VILANTEROL TRIFENATATE
- BREO ELLIPTA COMPONENT VILANTEROL TRIFENATATE
- D09697
- F11535
- VILANTEROL TRIFENATATE COMPONENT ANORO ELLIPTA
- TRELEGY ELLIPTA COMPONENT VILANTEROL TRIFENATATE
- A899729
- BRD-M36487418-001-01-4
- BRD-M36487418-001-02-2
- BRD-M36487418-001-03-0
- Q27145087
- 4-[(1R)-2-[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;2,2,2-triphenylacetic acid
- GW 642444X;GW-642444X;GW642444X
- VILANTEROL TRIFENATATE COMPONENT OF BREO ELLIPTA
- B0084-470923
- VILANTEROL TRIFENATATE COMPONENT OF TRELEGY ELLIPTA
- Triphenylacetic acid-4-((1R)-2-((6-(2-((2,6-Dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol (1:1)
- Benzeneacetic acid, alpha,alpha-diphenyl-, coMpd. with (alpha1R)-alpha1-[[[6-[2-[(2,6-dichlorophenyl)Methoxy]ethoxy]hexyl]aMino]Methyl]-4-hydroxy-1,3-benzenediMethanol (1
- TRIPHENYLACETIC ACID-4-((1R)-2-((6-(2-(2,6-DICHOLOROBENZYL)OXY)ETHOXY)HEXYL)AMINO)-1-HYDROXYETHYL)-2-(HYDROXYMETHYL)PHENOL (1:1)
- (R)-4-(2-((6-(2-((2,6-Dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol 2,2,2-triphenylacetate
- 4-((1R)-2-((6-(2-((2,6-Dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol mono(2,2,2-triphenylacetate)
- 4-((1R)-2-((6-(2-((2,6-Dichlorophenyl)methoxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol triphenylacetate
- 4-[(R)-2-[[6-[2-(2,6-Dichlorobenzyloxy)ethoxy]hexyl]amino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol triphenylacetate
- 4-[(R)-2-[[6-[2-(2,6-Dichlorobenzyloxy)ethoxy]hexyl]amino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol triphenylacetate; GW 642444M; Vilanterol trifenatate; Benzeneacetic acid, alpha,alpha-diphenyl-, compd. with (alpha1R)-alpha1-[[[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexyl]amino]methyl]-4-hydroxy-1,3-benzenedimethanol (1:1); GW 642444M
- 4-{(1R)-2-[(6-{2-[(2,6-Dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol mono(2,2,2-triphenylacetate)
- 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol triphenylacetate
- 6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}-N-{(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}hexan-1-aminium triphenylacetate
- Benzeneacetic acid, alpha,alpha-diphenyl-, compd. with (alpha1R)-alpha1-(((6-(2-((2,6-dichlorophenyl)methoxy)ethoxy)hexyl)amino)methyl)-4-hydroxy-1,3-benzenedimethanol (1:1)
- Benzeneacetic acid, alpha,alpha-diphenyl-, coMpd. with (alpha1R)-alpha1-[[[6-[2-[(2,6-dichlorophenyl)Methoxy]ethoxy]hexyl]aMino]Methyl]-4-hydroxy-1,3-benzenediMethanol (1:1)
- Triphenylacetic acid--4-{(1R)-2-[(6-{2-[(2,6-dichlorophenyl)methoxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1/1)